That's incorrect, you're thinking of drugs making it to phase 3. Historically final phase orphan drugs are usually a 55-60% chance of making it through to FDA approval. But agree with the overall sentiment.
DXB Price at posting:
48.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)